Anatomical Therapeutic Chemical • C10AX14 • alirocumab

A Alimentary tract and metabolism

B Blood and blood forming organs

C Cardiovascular system

C01 Cardiac therapy

C02 Antihypertensives

C03 Diuretics

C04 Peripheral vasodilators

C05 Vasoprotectives

C07 Beta blocking agents

C08 Calcium channel blockers

C09 Agents acting on the renin-angiotensin system

C10 Lipid modifying agents

C10A Lipid modifying agents, plain

C10AA Hmg coa reductase inhibitors

C10AB Fibrates

C10AC Bile acid sequestrants

C10AD Nicotinic acid and derivatives

C10AX Other lipid modifying agents

C10AX06 omega-3-ethyl esters 90 Indicated for: hypertriglyceridemia

C10AX06 icosapent ethyl Indicated for: hypertriglyceridemia; cardiovascular risk reduction

C10AX09 ezetimibe Indicated for: dyslipidemia

C10AX12 lomitapide Indicated for: homozygous familial hypercholesterolemia

C10AX13 evolocumab Indicated for: dyslipidemia

C10AX14 alirocumab Indicated for: dyslipidemia

C10AX16 inclisiran Indicated for: dyslipidemia

C10AX17 evinacumab Indicated for: dyslipidemia

C10AX18 volanesorsen Indicated for: dyslipidemia

C10B Lipid modifying agents, combinations

D Dermatologicals

G Genito urinary system and sex hormones

H Systemic hormonal preparations, excluding sex hormones and insulins

J Antiinfectives for systemic use

L Antineoplastic and immunomodulating agents

M Musculo-skeletal system

N Nervous system

P Antiparasitic products, insecticides and repellents

R Respiratory system

S Sensory organs

V Various